​

Aspira Women's Health (AWH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AWH Stock Forecast

Aspira Women's Health (AWH) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $3.30, with a high of $3.30 and a low of $3.30. This represents a 704.88% increase from the last price of $0.41.

- $1 $2 $3 $4 $5 High: $3.3 Avg: $3.3 Low: $3.3 Last Closed Price: $0.41

AWH Stock Rating

Aspira Women's Health stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (50.00%), 1 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

AWH Forecast vs Benchmarks

TypeNameUpside
StockAspira Women's Health704.88%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$3.30
Last Closing Price$0.41$0.41$0.41
Upside/Downside--704.88%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-11--2
Dec, 24-12--3
Nov, 24-12--3
Oct, 24-12--3
Sep, 24-12--3
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2024Ross OsbornCantor Fitzgerald$3.30$3.106.45%704.88%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Aug 14, 2024Alliance Global PartnersBuyBuyhold
Apr 01, 2024Cantor FitzgeraldNeutralNeutralhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-2.63$-4.28$-2.78$-1.81----
Avg Forecast$-2.35$-4.35$-4.24$-1.92$-1.20$-0.50$-0.26-
High Forecast$-2.74$-5.07$-5.17$-2.00$-1.20$-0.50$-0.26-
Low Forecast$-1.81$-3.35$-3.52$-1.83$-1.20$-0.50$-0.26-
Surprise %11.91%-1.61%-34.43%-5.73%----

Revenue Forecast

$0 $16M $32M $48M $64M $80M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$4.65M$6.81M$8.18M$9.15M----
Avg Forecast$4.53M$6.80M$8.26M$9.58M$11.00M$23.50M$32.66M$75.30M
High Forecast$3.73M$5.60M$7.18M$9.58M$11.00M$23.50M$32.66M$75.30M
Low Forecast$5.11M$7.67M$9.66M$9.58M$11.00M$23.50M$32.66M$75.30M
Surprise %2.57%0.18%-0.97%-4.41%----

Net Income Forecast

$-50M $-40M $-30M $-20M $-10M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-17.63M$-31.71M$-21.57M$-16.69M----
Avg Forecast$-21.70M$-40.16M$-29.68M$-16.69M$-11.08M$-4.62M$-2.40M-
High Forecast$-25.30M$-46.83M$-35.62M$-20.03M$-11.08M$-4.62M$-2.40M-
Low Forecast$-16.71M$-30.92M$-23.75M$-13.35M$-11.08M$-4.62M$-2.40M-
Surprise %-18.75%-21.05%-27.32%-----

AWH Forecast FAQ

Is Aspira Women's Health stock a buy?

Aspira Women's Health stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Aspira Women's Health is a favorable investment for most analysts.

What is Aspira Women's Health's price target?

Aspira Women's Health's price target, set by 2 Wall Street analysts, averages $3.3 over the next 12 months. The price target range spans from $3.3 at the low end to $3.3 at the high end, suggesting a potential 704.88% change from the previous close price of $0.41.

How does Aspira Women's Health stock forecast compare to the average forecast of its sector, industry, and investment themes?

Aspira Women's Health stock forecast shows a 704.88% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Aspira Women's Health over the past three months?

  • January 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Aspira Women's Health’s EPS forecast?

Aspira Women's Health's average annual EPS forecast for its fiscal year ending in December is -1.2 for 2024, a -33.70% decrease from the reported $-1.81 in 2023. The prediction for 2025 is $-0.5, $-0.26 for 2026, and $0 for 2027.

What is Aspira Women's Health’s revenue forecast?

Aspira Women's Health's average annual revenue forecast for its fiscal year ending in December is $11M for 2024, a 20.17% increase from the reported $9.15M in 2023. The forecast for 2025 is $23.5M, $32.66M for 2026, and $75.3M for 2027.

What is Aspira Women's Health’s net income forecast?

For its fiscal year ending in December, Aspira Women's Health's average annual net income forecast is $-11.08M for 2024, reflecting a -33.61% decrease from the reported $-16.69M in 2023. The projection for 2025 is $-4.617M, $-2.401M for 2026, and $0 for 2027.